Partnerships
Page: FIP Practice Transformation
FIP practice transformation programme on non-communicable diseases: Programme booklet (2023)
The FIP practice transformation programme (PTP) on non-communicable diseases (NCDs) aims to provide strategic support and tools
to FIP member organisations to develop and implement pharmacy services that can have a sustained positive impact in the prevention,
screening, management, and treatment optimisation of NCDs for improved patient outcomes and health systems efficiency and sustainability.
FIP Practice Transformation Programme on Non-communicable Diseases: Programme overview (2023)
The FIP practice transformation programme (PTP) on non-communicable diseases (NCDs) aims to provide strategic support and tools
to FIP member organisations to develop and implement pharmacy services that can have a sustained positive impact in the prevention,
screening, management, and treatment optimisation of NCDs for improved patient outcomes and health systems efficiency and sustainability.
Management of non-communicable diseases: Regulatory self-assessment and development tool for transforming pharmacy practice
Regulators, ministries of health, policymakers and national pharmacy organisations are encouraged to assess regulations in their country related to pharmacy-based care of non-communicable diseases (NCDs) with a development tool developed by FIP’s Forum of Pharmacy Professional Regulators. This tool is based on experiences from countries where pharmacy services targeting NCDs (including testing, measurement of parameters, such as blood pressure and peak expiratory volume, and prescribing or modifying prescriptions) have been successfully introduced and regulated, and on researched pharmacy practice legislation from around the world.
FIP Practice Transformation Programme on Non-Communicable Diseases: Presentation and support from FIP to member organisations
The FIP Practice Transformation Programme on non-communicable diseases (NCDs) aims to provide tools and strategic support to FIP member organisations to develop and implement pharmacy services that can have a sustained positive impact in the prevention, screening, management, and treatment optimisation of NCDs for improved patient outcomes and health systems efficiency and sustainability. An overview of the programme can be found in a short video available in English, Spanish and French.
While the project will have a particular focus on low-and-middle-income countries, it will encourage implementation by countries of all income levels, since the goals of optimising NCDs management and reducing the burden of these diseases is a global imperative.
With this event for FIP member organisations only, FIP leadership (including the FIP President, CEO and other officers) and HQ team members will describe how the programme will work, what resources are available and how FIP may support its member organisations in implementing the programme at country level.
Member organisations will learn about:
- The programme aims, mission and vision;
- The programme description, including the five disease areas, pharmacist interventions in these different areas, and the domains of transformation where FIP may offer support to member organisations;
- The programme approach and process;
- The programme principles and scope;
- The programme deliverables so far.
Cardiovascular diseases: A handbook for pharmacists (2022)
This handbook identifies and describes pharmacist-led interventions in cardiovascular disease prevention, screening, management, and treatment optimisation to both support their implementation in pharmacy practice and to support advocacy efforts towards the optimisation and expansion of pharmacists’ scope of practice in cardiovascular diseases and NCDs in general.
This publication is available in the following languages:
Transforming pharmacy practice for improved care and management of cardiovascular diseases
The World Health Organization estimate that 17.9 million people die from cardiovascular diseases each year, representing 32% of all global deaths. Pharmacists have a role to play in the prevention, care and management of cardiovascular diseases and their complications. FIP has developed a new handbook to support pharmacists and their organisations in providing a range of cardiovascular diseases-related services. This handbook — which will be launched at this event — also identifies the knowledge and skills that pharmacists require for the provision of such services, thus offering guidance to academic institutions and CPD providers. This handbook is part of the FIP Practice Transformation Programme on Non-Communicable Diseases
Transforming pharmacy practice for improved care and management of cancer
Cancer is the second leading cause of death globally, according to the World Health Organization. Prevention and early screening are crucial elements of interprofessional strategies to reduce the burden, morbidity and mortality associated with cancer, as are medication management for optimal outcomes, and patient support. Pharmacists have a key role to play in all these areas. At this digital event, FIP will be publishing a new handbook to support pharmacists and their organisations in providing a range of cancer-related services. In addition, the handbook will be accompanied by the knowledge and skills (K&S) reference guide in cancer which identifies the K&S that pharmacists require for the provision of such services, thus offering guidance to pharmacists, academic institutions and CPD providers. Both publications will be launched at this event, and they are part of the FIP Practice Transformation Programme on Non-Communicable Diseases.
